Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission.

Nguyen, Phillip C; Donati, Vanessa; Vassili, Catherine; Grigg, Andrew P; Tiong, Ing S

Nguyen, Phillip C; Donati, Vanessa; Vassili, Catherine; Grigg, Andrew P; Tiong, Ing S.

Afiliación

Nguyen PC; Department of Clinical Hematology, Alfred Hospital and Monash University, Melbourne, Australia.
Donati V; Department of Clinical Haematology, Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia.
Vassili C; Department of Clinical Hematology, Alfred Hospital and Monash University, Melbourne, Australia.
Grigg AP; Department of Clinical Haematology, Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia.
Tiong IS; Department of Clinical Hematology, Alfred Hospital and Monash University, Melbourne, Australia; Department of Clinical Haematology, Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia. Electronic address: ing-soo.tiong@austin.org.au.

Leuk Res ; 116: 106837, 2022 05.

Article en En | MEDLINE | ID: mdl-35400541

Asunto(s)

Antifúngicos; Leucemia Mieloide Aguda; Antifúngicos/efectos adversos; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Azoles; Compuestos Bicíclicos Heterocíclicos con Puentes/efectos adversos; Humanos; Leucemia Mieloide Aguda/tratamiento farmacológico; Sulfonamidas

Palabras clave

AML; Tolerability; Toxicity; Venetoclax

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Antifúngicos Límite: Humans Idioma: En Revista: Leuk Res Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google